News Feature | May 28, 2015

Deal Struck To Accelerate Clinical Studies In Digital Health

Christine Kern

By Christine Kern, contributing writer

HIPAA Rules With VARs

PokitDok helps to virtually, securely, and efficiently identify eligible participants for clinical trials.

Evidation Health and PokitDok have announced a new partnership that will enable them to virtually, securely, and efficiently identify eligible participants for clinical trials and connect digital interventions with the resulting health outcomes.

“We are excited to leverage digital solutions such as PokitDok to more efficiently and effectively execute real-world clinical studies that will inform patient management strategies and accelerate progress toward precision digital medicine,” said Deborah Kilpatrick, CEO, Evidation Health.

The PokitDok technology enables Evidation to access data from nearly 300 insurers, including United Health, Wellpoint, Aetna, Cigna, Humana, and Kaiser, in addition to Medicare and Medicaid. Information includes a person's deductible and amount satisfied, their coverage level and co-pay, benefit enrollment submission or changes to a covered member's plan, as well as claims status and submission.

“The future of medicine is digital,” said Lisa Maki, co-founder and CEO, PokitDok. “We’ve shifted from a reliance on clinic visits to incorporating digital tools and services that can be accessed anywhere, at any time. While new digital health apps and wearables make virtual medicine possible – measurable evidence that these tools work must be coupled with contextually relevant connections back to the doctor and economic data to the insurers to confirm patient outcomes as well as financial value. PokitDok’s partnership with Evidation introduces a practical way to concretely measure the success of emerging digital health tools both clinically and financially.”

Med City News further explains the collaboration is part of an initiative by Evidation to begin evaluating the massive number of digital health apps, relatively few of which have been submitted to the rigors of clinical validation, in order to develop a better way of helping payers and provides identify the best digital health tools for patients.